Vegrandis is a market-focused leader in microelectrochemical detection and carbon nanopipette applications. The company designs and builds nanoelectrochemical detection based point-of-care clinical assays, chemical/biological sensors, microarrays, laboratories-on-a-chip, reagent kits, and also carbon nanopipettes for cell electrophysiology and cellular injection applications. Vegrandis is committed to meet the needs of environmental monitoring, point-of-care diagnostics, bioterrorism defense and intracellular nanosurgery with disposable devices and inexpensive, easy to use instrumentation that accelerates analyses while reducing laboratory costs.